This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The following 10 predictions that we have made for the global healthcare will define new ways of rethinking business and growth opportunities in 2021, and will help determine the future direction of the industry. By the end of 2021, about 4 billion COVID-19vaccine doses will be delivered globally.
Two pharmaceutical giants of the pandemic, Moderna and BioNTech, are taking steps for increasing the manufacturing capacity for the COVID-19vaccine in Africa. Last March, Moderna announced its plan to set up a manufacturing facility in Kenya to produce messenger RNA (mRNA) vaccines, including COVID-19 shots.
Current vaccine and treatment inequity was not inevitable. Early on in the pandemic, the WorldHealth Organization (WHO) proposed IP owners voluntarily license IP to others to ensure affordable COVID treatments. Existing international and domestic IP rules allow IP owners to voluntarily share their IP rights.
First announced in January 2021, the Vaccine Credential Initiative – co-founded by MITRE Corporation and others including Cerner, Change Healthcare, Epic, Mayo Clinic, Microsoft, Oracle, Salesforce and others – has made big progress over the past year-plus on new approaches to interoperable record-keeping.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the WorldHealth Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19vaccines.
As I previously discussed in October of 2020, Moderna pledged not to enforce its patents against makers of COVID-19vaccines during the pandemic. Then, in 2022, Moderna sued competing vaccine makers Pfizer and BioNTech. Conclusion The U.K.
At the end of 2021, Thomas Cueni, the head of an international pharmaceutical trade association, acknowledged that everyone was “ashamed and embarrassed” by the inequity. “We Consider the United States, for example, which made the unprecedented move to leave the WorldHealth Organization (WHO) during the pandemic.
SQA Regulatory Surveillance Summary #3, 2021. Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19vaccine exports.
Since the WorldHealth Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented with the EMA reporting a 93% increase in the volume of adverse event reports reported in 2021 compared to 2020 1. . New advances in technology (e.g., References.
A little over one week later, we reported that the WorldHealth Organization declared a global health emergency after COVID-19 was detected in eighteen countries, infecting almost 10,000 people and killing more than two hundred.
The COVID-19 pandemic hit Africa hard and overwhelmed the capacity to test for and treat the disease, highlighting existing gaps within its national health systems. Health resources are unevenly distributed and often of poor quality. Hesitancy: a convenient scapegoat.
On Friday, November 26, 2021, the WorldHealth Organization (“WHO”) reported a new variant of COVID-19, the Omicron variant, was detected in South Africa. There is no indication the new variant is more contagious or more lethal, or that it is resistant to the COVID-19vaccine.
An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, WorldHealth Organization (“WHO”), or if administered as a part of a clinical trial.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content